Transaktionen anzeigen
Gesundheitswesen

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition, the raise will be used to scale up manufacturing and device activities.

Synairgen engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease and severe viral infections, as well as COVID-19. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as advisor to Synairgen plc in this transaction.

DIENSTLEISTUNG
Beschaffung von Kapital
PARTEIEN
«It was particularly pleasing to see the level of support received for this financing, reinforcing confidence in SNG001, our wholly-owned drug and potential breakthrough treatment for COVID-19 patients. Oaklins’ team has always been supportive and built a good register of institutions in March which was broadened further in this funding. It was a very successful fundraising and the level of demand was such that we were comfortably able to increase the size of the funding. Having demonstrated the great promise of SNG001 in hospitalized COVID-19 patients earlier this year, we now have the resources to be able to rapidly progress this potential breakthrough treatment in such a critical area of unmet need.»

Richard Marsden

CEO, Synairgen plc

Sprechen Sie mit dem Deal Team

 Geoff  Nash

Geoff Nash

Partner

London, Grossbritannien
Oaklins Cavendish

Transaktionen

Laptaria cu Caimac has completed an IPO
Lebensmittel- und Getränkeindustrie

Laptaria cu Caimac has completed an IPO

Laptaria cu Caimac has raised US$5 million through a private placement of shares on the ATS Market of BSE. The funds will be used for the development of the factory, namely, the construction of a bottle and jar washing station, utility systems and packaging storage.

Mehr erfahren
Nutricare has raised 3.1 million via an entitlement offer
Handel | Gesundheitswesen

Nutricare has raised 3.1 million via an entitlement offer

Nutricare Pty Ltd has raised funds to support its growth strategy.

Mehr erfahren
Alexandria Pankkiiriliike Oyj has raised US$9.7m in the course of its IPO on NASDAQ First North Finland
Finanzdienstleistungen

Alexandria Pankkiiriliike Oyj has raised US$9.7m in the course of its IPO on NASDAQ First North Finland

Alexandria Pankkiiriliike Oyj (Alexandria) has raised US$9.7 million in the course of its IPO.

Mehr erfahren